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*On leave from Department of Embryology, Institute of Zoology, University of Warsaw, Krakowskie Przedmiescie 26/28, 00-927 Warsaw, PolandWe describe the use of a DNA construct (named GFP.RN3)
encoding green fluorescent protein as a lineage marker for
Xenopus embryos. This offers the following advantages
over other lineage markers so far used in Xenopus. When
injected as synthetic mRNA, its protein emits intense fluo-
rescence in living embryos. It is non-toxic, and the fluores-
cence does not bleach when viewed under 480 nm light. It
is surprisingly stable, being strongly visible up to the
feeding tadpole stage (5 days), and in some tissues for
several weeks after mRNA injection. We also describe a
construct that encodes a blue fluorescent protein. We
exemplify the use of this GFP.RN3 construct for marking
the lineage of individual blastomeres at the 32- to 64-cell
stage, and as a marker for single transplanted blastula
cells. Both procedures have revealed that the descendants
of one embryonic cell can contribute single muscle cells to
nearly all segmental myotomes rather than predominantly
to any one myotome. An independent aim of our work has
been to follow the fate of cells in which an early regulatory
gene has been temporarily overexpressed. For this purpose,
we co-injected GFP.RN3 mRNA and mRNA for the early
Xenopus gene Eomes, and found that a high concentration
of Eomes results in ectopic muscle gene activation in only
the injected cells. This marker may therefore be of general
value in providing long term identification of those cells in
which an early gene with ephemeral expression has been
overexpressed.
Key words: Xenopus, green fluorescent protein, marker, Eomes, cell
lineage, GFP.RN3
SUMMARYINTRODUCTION
Many important Xenopus transcription factors are strongly
expressed in early development, but cease to be expressed a
few hours later (Smith, 1993; Dawid, 1994). To determine the
function of such genes, one important experimental route is to
express them ectopically in a tissue where they are not
normally functional, and to ask if the cell fate is changed.
However, most markers of cell fate are expressed only after
the time when early regulatory genes have ceased to be so. This
makes it difficult to relate the overexpression of such a gene
in any precise way to a change of cell fate. Thus, in the absence
of a lineage marker, it is not clear whether the cells that over-
express a gene themselves change fate, or whether these cells
signal to their neighbours to do so. A long-lasting lineage
marker is needed to provide continuing recognition of the cells
in which an early, but temporary, overexpression has taken
place.
The lineage markers so far used in Xenopus are subject to
certain limitations (reviewed by Slack, 1983; Smith et al.,
1985; Gardner and Lawrence, 1986). Injected colloidal gold
particles (Niehrs and De Robertis, 1991) are suitable for
whole-mount analyses but are subject to dilution as cell
number increases with growth. Fluorescent lysinated dextrans
(e.g. Gimlich and Braun, 1985) are not necessarily distributedto the same blastomeres as the injected mRNAs commonly
used to achieve ectopic expression. Furthermore, they become
hard to detect as development proceeds, and are unstable to the
ultraviolet light required to see them. mRNAs encoding
enzymes such as b -galactosidase and horseradish peroxidase
should be equally distributed, but have to be visualized by
substrate reactions, which do not always give accurate local-
ization of the enzyme. Most importantly, none of these lineage
markers can be seen in living cells. A potentially ideal lineage
marker is provided by the green fluorescent protein of
Aequorea victoria (Chalfie et al., 1994). However, the green
fluorescent protein so far used in Xenopus embryos (Tannahill
et al., 1995) gives only a moderate strength of signal, and is
not expressed until the neurula stage. Peters et al. (1995)
suggest that, due to background yolk fluorescence, GFP fusion
proteins will have limited utility in Xenopus. Wu et al. (1995)
used a recombinant vaccinia virus containing a GFP gene to
infect the brain of 3-day Xenopus tadpoles, but not embryos.
We describe here the use of a modified construct (GFP.RN3)
encoding green fluorescent protein; this provides a very long
lasting and brilliant fluorescence, far exceeding the low level of
autofluorescence of Xenopus embryos. We apply this lineage
marker to follow the fate of cells ectopically expressing the
Xenopus gene Eomes. Eomes encodes a T-domain transcription
factor capable of activating nearly all other early Xenopus
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Fig. 1. Whole embryos or larvae labelled by injecting 1 ng GFP.RN3
mRNA into the animal hemisphere of each of the first two
blastomeres. (A) Stage 8.5; (B) stage 20; (C) stage 25; (D) stage 37;
(E) stage 47; (F) epithelial cells of stage-47 tadpole (all are GFP-
positive, but some are brighter than others). (G) Lens of stage-49
tadpole; (H) same view as G, but of unlabelled control tadpole. The
black patches in A-D (and also in Fig. 2A-C) are due to pigment. The
yellow regions in E are due either to gut autofluorescence or to the
photographic consequence of very high intensity green fluorescence
associated with the lens and residual sucker (see legend to Fig. 3D).regulatory genes. However, as indicated above, Eomes tran-
scripts are no longer present by the time when most cell fate
markers can be detected (K. Ryan, N. Garrett, A. Mitchell and
J. B. Gurdon, unpublished). GFP mRNA, coinjected with
Eomes mRNA, enables us to identify those cells in which
Eomes was overexpressed, and hence to relate the ectopic
expression of Eomes to a particular type of differentiation.
In the course of this work, we have found that the
GFP.RN3 construct we have used creates such long lasting
and strong fluorescence that it is likely to be a reagent of very
wide application (see Discussion). To test its usefulness as a
lineage marker, we have labelled single cells of an early
blastula to follow lineage, and have transplanted single
labelled blastula cells to unlabelled hosts. We have followed
the distribution of the lineage descendants of the labelled
cells into a range of larval tissues, especially muscle, formed
a few days later.
MATERIALS AND METHODS
GFP and BFP mutagenesis
The modified GFP constructs were generated from mgfp5. mgfp5
incorporates two mutations that improve the folding of the apoprotein
at higher temperatures, and thus enhance the solubility of GFP (K. R.
S., R. Golbik, R. Sever and J. H., unpublished observations). This sub-
stantially increases the fluorescence signal. A third mutation, I167T
(Heim et al., 1994) increases the absorption of GFP in the blue part
of the spectrum. In addition, mgfp5 incorporates a number of codon
changes that remove a cryptic splice site, which is recognised in plants
(J. H., K. R. S., D. Prasher and S. Hodge, unpublished observations),
and these changes might also have an effect on mRNA processing
and/or translational efficiency in animal cells. Two mutations, F64L
and S65T, were introduced into mgfp5 by PCR mutagenesis. The
S65T mutation enhances the second peak of absorption (Heim et al.,
1995) and the F64L mutation (Cormack et al., 1996) enhances the sol-
ubility of GFP, at least when it is expressed in bacteria. Two other
mutations, H25Y and G191D, were inadvertantly introduced during
PCR mutagenesis and identified by A. Brand and C. Davidson, but
have no discernable effect on the fluorescence intensity of our
modified GFP (J.P., unpublished observations). The modified BFP
construct was also derived from mgfp5. It contains the Y66H (Heim
et al., 1994) and Y145F (Heim and Tsien, 1996) mutations that shift
the absorption of GFP towards the UV, and the emission into the blue
part of the spectrum, plus a third mutation, A87T, whose effect is
presently unknown.
The mutated GFP, as encoded by our GFP.RN3 construct, is easily
visible with a standard FITC filter set, namely with FITC excitation
filters BP 450-490 nm, a 510 nm dichromatic mirror and a 515 nm
suppression filter. Our BFP is seen with standard DAPI excitation
filters BP 355-425 nm, a 455 nm dichromatic filter and a 470 nm sup-
pression filter.
RN3 constructs
The GFP and BFP gene coding regions were PCR-amplified from
parental vectors (pCMXF64GFP and pCMXBFP, respectively) and
cloned in the vector pBluescript RN3P (a MCS-containing derivative
of pBluescript RN3, Lemaire et al., 1995; D. Crease, personal com-
munication) between the BamHI (5¢ ) and NotI (3¢ ) sites. These genes
were modified to contain a Xenopus b -1-globin ribosome binding site
[ACAGCCACC(ATG)] at the 5¢ end (K. Ryan, N. Garrett, A.
Mitchell and J. B. Gurdon, unpublished) and stop codons in all three
reading frames at the 3¢ end by inclusion of the appropriate sequences
in the PCR primers. The resulting clones were named p b GFP/RN3P
and pb BFP/RN3P.Microinjection
mRNA was synthesized, eggs or embryos injected, and embryos
cultured as before (Lemaire et al., 1995).
Histology and antibody staining
Embryos were fixed for 2 hours in 4% formaldehyde, dehydrated,
embedded in hot wax after xylene treatment, sectioned and stained
with antibody (Kintner and Brockes, 1984) as in our previous work
(Gurdon et al., 1993a).
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GFP and BFP constructs
Compared to the GFP first described (Prasher et al., 1992), a
number of amino acid changes have been introduced. These
are described in Materials and Methods.
The GFP and BFP sequences have been cloned into the high
expression vector bluescript RN3, described by Lemaire et al.
(1995). The GFP cDNA RN3 has been further modified by the
addition of a ribosome binding site (see Materials and
Methods).
Whole embryo labelling
To test the efficacy of our construct, we injected GFP.RN3
mRNA (1 or 2 ng) into 2-cell eggs and cultured these as whole
embryos until the feeding larval stage. The results shown in Fig.
1 permit the following conclusions. (1) GFP.RN3 expression is
strongly visible at stage 8 (Figs 1A, 2A,C), 4 hours after mRNA
injection. It is first seen 1.5 hours after injection, when 2-cell
embryos have reached the 32-cell stage, at 23°C. (2) GFP.RN3
is evenly expressed in epidermal cells, the direct descendants
of the region of eggs injected with mRNA (Fig. 1A-D). (3)
GFP.RN3 fluorescence persists with strong intensity until at
least stage 41 (80 hours after injection), and can still be detected
in stage-53 tadpoles (3 weeks after injection, weakly in all cells
of the injected lineage but very strongly in the lens, as in Fig.
1E). The longevity of GFP.RN3 as a fluorescent marker may
be due to both mRNA and protein stability. The amount of
injected GFP.RN3 mRNA starts to decline at stage 18, declines
to 24% of its original level at stage 26, and to 0.5% at stage 46.
GFP.RN3 fluorescence is particularly long lasting in those cells
which cease division during embryo life, such as lens (Fig.
1G,H) and muscle (Fig. 2I,J). (4) GFP.RN3 fluorescence is suf-
ficiently intense that details of tissue structure can be readily
detected by confocal microscopy right through embryogenesis
and larval life (Fig. 1F). (5) At least 2 ng per embryo of
GFP.RN3 mRNA and its derived protein appear entirely
harmless, since injected eggs grow normally to mid-larval life
and beyond. Furthermore, frequent viewing of live embryos
under 480 nm light also appears harmless. 
Lineage labelling
Although there are very detailed descriptions of cell lineage
from 32-cell Xenopus embryos (Jacobson and Hirose, 1981;Fig. 2. GFP.RN3- or BFP-labelling of single blastomere lineages.
(A,B) 1 ng of GFP.RN3 mRNA injected into one of first two
blastomeres; (A) stage 8, animal pole; (B) stage 18, right half of
neural plate. (C-F) Injection of a single tier A blastomere at the 32-
to 64-cell stage with GFP.RN3 mRNA; the descendants of this cell
become progressively dispersed; (C) stage 8, animal pole; (D) stage
18 (labelled cells in left-hand neural fold); (E) stage 24; (F) stage 35
(labelled cells in anterior (head) region in E and F). (G,H) Injection
of two adjacent tier A blastomeres on one side of a 16- to 32-cell
embryo, one with with BFP, and the other with GFP.RN3; (G) stage
18; (H) stage 26, higher magnification. (I,J) Injection of a single
blastomere in tier B at the 32- to 64-cell stage with GFP.RN3
mRNA. Note labelling of individual muscle cells in each segment (I)
and in interspersed or alternating segments (J). I and J both show the
tail region of stage-40 tadpoles (head out of view to the left in I, right
in J). The white lines outline the shape of the tail and two single
somites containing at least 100 muscle cells. Dale and Slack, 1987; Moody, 1987; Nakamura and Kishiyama,
1971; Nakamura et al., 1978), little has been reported for later
stages (Jacobson, 1983, 1985). Furthermore, all of the lineage
markers so far used successfully in Xenopus (see Introduction)
have the restriction that only fixed embryos can be analyzed.
This means that the same lineage can never be viewed in one
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3722 M. Zernicka-Goetz and othersembryo, a disadvantage since, in Xenopus, the pattern of
cleavage (and thus the lineage of labelled cells) is by no means
identical in all embryos. This constraint does not apply to
GFP.RN3, which can be viewed in living cells. We have
followed the descendants of single injected blastomeres, by
viewing the same living embryos over several days.
When GFP.RN3 mRNA is injected into only one blastomere
of a 2-cell egg, the green fluorescent cells are always seen to
be dispersed widely on one side of the embryo, but to be
virtually or more often completely absent on the other side
(Fig. 2B). We therefore see that this marker does not cross cell
walls and that there is no detectable mixing of epidermal cells
between the two sides of an embryo. The intensity of the flu-
orescence provides a sensitive test of this conclusion.
We have examined in more detail the lineage of single blas-
tomeres injected at the 32- to 64-cell stage. Blastomeres of the
A tier (nearest the animal pole) give rise to groups of cells that
are at first localized to a small region of the blastula, but they
become progressively intermixed with their neighbours as
development proceeds (Fig. 2C-F).
Single cells from the B or C tiers of 32- to 64-cell embryos
nearly always contribute to internal cells, especially muscle, but
often to some epidermal cells as well. The distribution of cells
in muscle has given the surprising result that the GFP.RN3-
marked cells (from one blastomere) generally contribute to a
large number of myotomes, but to only a few muscle cells
within each myotome (Fig. 2I-J). Remarkably, we often see an
alternating, or at least interspersed, distribution of single muscle
cells (Fig. 2J). This suggests that several stem cells are often
formed from certain B or C blastomeres, and that these continue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Fig. 3. Transplantation of a single stage-8, GFP.RN3-labelled cell
into the blastocoel of an unlabelled stage-8 host. (A) stage 10;
(B) stage 12; (C) stage 38; (D) stage 45. (A-C) Animal cap cell;
(D) equatorial cell. In D the intestine appears yellow due to
autofluorescence that develops in the tadpole gut. This
autofluorescent yellow is unrelated to green fluorescence and is very
clearly distinguishable when viewed under the microscope. The
yellow spots in the middle of the single green cells in A-C are an
artefact of photographic film, and are seen under the microscope as
maximum intensity green (but not yellow) fluorescence.to contribute individual cells to many myotomes during tail
formation. Thus the muscle cells that comprise a single
myotome originate from several early blastomeres.
Blastomeres from the D tier of 32- to 64-cell embryos con-
tribute, as would be expected (Dale and Slack, 1987; Moody,
1987), very largely to the endoderm and gut.
For some experiments, it is helpful to have a second lineage
marker that can be used in conjunction with the first, and
observed under the same conditions. We have mutated
GFP.RN3 to obtain a blue fluorescence (Materials and
Methods). Our BFP.RN3 causes cells to emit a blue fluorescence
under UV light (380 nm). Like GFP.RN3, BFP.RN3 can be seen
in living embryos, though it is gradually bleached by the UV
light. It is not as intense as the GFP, the latter being so strong
that it can be seen at the same time as the BFP under 380 nm
light (Fig. 2G,H). BFP can therefore be used as a lineage marker
complementary to GFP.RN3, after injection of its mRNA.
Single cell transplantation
Although not often carried out, the transplantation of single cells
to ectopic sites in an embryo can give valuable information on
the importance of local cell interactions (Heasman et al., 1984;
Kato and Gurdon, 1992). In contrast to lineage studies, which
determine the fate of cells surrounded by their natural neighbours
in a wholly undisturbed normal development, cell transplantation
is able to reveal signalling interactions between cells of a kind
that would never be evident by observing normal cell lineages.
It has been observed in insects as well as in Xenopus that several
cells transplanted as a group will maintain their differentiation (or
commitment to differentiate), whereas the same cells transplanted
singly will not do so (Cockcroft and Gardner, 1987; Technau,
1987; Stüttem and Campos Ortega, 1991; Gurdon et al., 1993a).
Experiments of this kind have led to the concept of the
community effect (Gurdon, 1988; Gurdon et al., 1993b).
The markers so far used for such experiments do not permit
the transplanted cell and its descendants to be followed during
the development of a single living embryo. We have tested the
usefulness of our marker for such experiments, by transplant-
ing single GFP.RN3-expressing cells from a stage-8 embryo
into the blastocoel of unlabelled stage-8 hosts, a procedure
described before by Heasman et al. (1984). We find that the
descendants of such transplanted cells can be readily seen in
living embryos, at least up to tadpole stages (Fig. 3A-D). There
is no detectable spread or loss of GFP.RN3 from the descen-
dants of the transplanted cells and their descendants.
Just as we observed in our lineage experiments (above), we
find that the progeny of a single transplanted cell at first remain
near each other but become widely dispersed and intermingled
with other cells during neurula and elongation stages. The dis-
tribution of single transplanted cells whose progeny contain
muscle cells is of special interest, and permits two conclusions.
First, a stage-8 blastomere often generates both muscle and
non-muscle (usually epidermal) progeny; therefore commit-
ment to muscle has not taken place by this stage. Second, we
see, as in lineage analyses, that a single stage-8 blastomere will
commonly contribute a single muscle cell to the myotomes of
several segments along the axis of a stage-40 or later tadpole
(Fig. 3D). From these kinds of experiments, we see that our
GFP.RN3 construct can provide a valuable marker for cell
transplantation experiments, as it should also for the continu-
ous observation of migrating germ cells, neural crest cells, etc.
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Fig. 4. Use of GFP.RN3 to determine the fate of cells overexpressing
Eomes. 2-cell embryos were injected with a mixture of 1 ng
GFP.RN3 mRNA and 2 ng Eomes mRNA into one blastomere at the
2-cell stage. This was done in order to achieve animal caps of which
only part was induced to form muscle, the rest serving as a no-muscle
control. Embryos were cultured to stage 8, when animal caps were
removed and placed face to face in pairs, and cultured to control stage
26. (A) An animal cap double conjugate showing GFP.RN3
fluorescence in tissue projections caused by Eomes overexpression.
(B) Transverse section of conjugate in A stained with 12/101 muscle
specific antibody; (C) same sample under green fluorescence. Note
that the strongly fluorescent extensions (A and C) are heavily stained
with the muscle antibody (B), but that the central part of the conjugate
(not extended) contains few GFP.RN3-containing cells and no 12/101
muscle antibody staining. The dark periphery of the central body is
attributable to pigment and not to antibody staining.GFP.RN3 and Eomes expression
Our initial aim was to use GFP.RN3 as a long lasting marker
of ephemeral Eomes expression. When Eomes is ectopically
expressed in blastula animal caps, by mRNA injection into 2-
cell eggs, it can induce almost all known early Xenopus genes
and a range of later cell-type specific markers, including those
for muscle (K. Ryan, N. Garrett, A. Mitchell and J. B. Gurdon,
unpublished). Since Eomes mRNA has disappeared by the stage
when muscle markers appear, it is not clear whether muscle is
induced in cells that were themselves overexpressing Eomes, or
whether those cells signal to other cells to do so.
To answer this question, we injected a mixture of Eomes and
GFP.RN3 mRNAs into one of the cells of a 2-cell egg (see legend
to Fig. 4). We isolated animal caps, placed two of these face to
face with each other to provide a larger conjugate with GFP- and
non-GFP-containing regions, and then cultured these conjugates
until stage 26, when they were tested for expression of the
terminal muscle marker 12/101 (Kintner and Brockes, 1984).
Fig. 4A shows that certain regions of the conjugates have
greatly elongated into extensions, which are strongly marked
by GFP.RN3 and therefore derive from GFP.RN3- and Eomes-
containing cells. This makes it clear that Eomes causes cell
elongation, an indication of gastrulation movements charac-
teristic of mesoderm, but not of normal animal cap cells. Sub-
sequent sectioning and antibody staining shows that the
regions most strongly labelled by GFP.RN3 are also those that
are clearly positive for 12/101 antibody staining (Fig. 4B,C).
Although occasional green cells are seen in the 12/101-
negative region, there is a high density of GFP.RN3-positive
cells in the areas most strongly stained by the muscle marker.
We conclude that muscle cell fate is a direct response of cells
to a high level of Eomes. We see no evidence that Eomes can
induce non-Eomes-containing cells to adopt a muscle fate.
DISCUSSION
The original aim of this work was to provide a way of marking
those cells in which an early regulatory gene has been over-
expressed, in order to assess the effect of overexpression on
the cell fate. The Xenopus gene Eomes, like many other early
developmental genes encoding transcription factors, is
expressed only briefly and its transcripts are no longer
detectable a few hours after its initial activation, well before
most markers of cell fate have appeared. The mRNA for the
two fluorescent protein-encoding constructs described here can
be mixed with other mRNAs for injection by the usual over-
expression procedure used in Xenopus. We suppose that two
mixed mRNAs are more likely to be distributed to the same
daughter cells than, for example, dextran and mRNA. It would
not be difficult to make a dicistronic construct for our fluor-
escent protein and another gene, such that a single injected
mRNA will generate both proteins. In the results reported here,
we note that the muscle marker 12/101 is not expressed in all
GFP.RN3-containing cells (and therefore in all those cells that
previously expressed Eomes); it is expressed only in a coherent
group of GFP.RN3-containing cells, a situation reminiscent of
the community effect (Gurdon et al., 1993a). 
We believe that the GFP.RN3 construct described here may
be of general value for other embryological work in Xenopus,
for the following reasons: (1) GFP fluorescence is intenselyvisible in single living cells. The injection of 1 ng of GFP.RN3
mRNA generates an intensity of signal in tail-bud tadpoles 40
times stronger under the fluorescence microscope than the
injection of 30 ng of rhodamine-lysinated dextran. Therefore
GFP mRNA generates a signal over 1000 times stronger than
the traditional rhodamine lineage tracer. (2) At least 2 ng mRNA
injected per embryo is not toxic. (3) GFP fluorescence can be
seen 1.5 hours after injection. (4) There is no significant auto-
fluorescence when viewing GFP.RN3. (5) It is not bleached by
the 480 nm absorption wavelength. (6) The protein is very stable.
3724 M. Zernicka-Goetz and others(7) GFP.RN3 is evenly distributed in cells descended from the
region of egg injection. (8) This GFP.RN3 withstands traditional
histological procedures, although with reduced intensity.
These qualities should enable this marker to be used to
answer a number of important questions concerning vertebrate
cell lineage. The original work describing compartments in
Drosophila and the restrictions they place on the spread of
embryonic cell descendants (Morata and Lawrence, 1975)
depended not only on the use of Minute mutant cells (Simpson
and Morata, 1981), but also on the availability of a long-
lasting cell lineage marker (reviewed by Lawrence and Struhl,
1996). Further work with our GFP.RN3 and BFP markers
could reveal the extent of compartment-like restrictions in ver-
tebrate development.
The results we describe here, in which a single embryo cell
contributes only one or a few muscle cells to many segments,
suggests that several equatorial cells of a 32-cell embryo con-
tribute muscle-forming stem cells; these stem cells then generate
muscle cells continuously as successive segments are formed. A
similar conclusion was reached for chick development by
Primmett et al. (1989) using 3H-thymidine pulse-labelling of
somites, and by Selleck and Stern (1991) using DiI-labelling of
small groups of future notochord cells (see Stern et al., 1992).
We thank F. Stennard and A. Mitchell for their help with some
technical procedures, and A. Brand and C. Davidson for pointing out
the presence of the H25Y mutation in GFP.RN3. M. Z.-G. thanks
EMBO for a Long Term Research Fellowship. This work was
supported by a Cancer Research Campaign programme grant SP
2184/0101 to J. B. Gurdon.
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